1 Ross R. Peptide regulatory factors:platelet-derived growth factor. Lancet, 1989, Ⅰ(8648):1179-1182. 2 Daynes RA, Dowell T, Araneo BA, et al. Platelet-derived growth factor is a potent biologic response modifier of Tcells. J Exp Med, 1991,174:1323-1333. 3 LeRoy EC. The control of fibros is in systemic sclerosis:a strategy involving extracelluler matrix, cytokines, and growth factors. J Dermatol, 1994, 21:1-4. 4 Krane JF, Murphy DP, Gottlieb A B, et al. Increased dermal expression of platelet -derived growth factor receptors in growth-activited skin wounds and psoriasis. J Invest Dermatol, 1991, 96:983-986. 5 Klareskog L, Gustafsson R, Scheynius A, et al. Increased expression of platelet -derived growth factor type Breceptors in the skin of patient swith systemics clerosis. Arthritis Rheum, 1990, 33:1534-1541. 6 Pandofi A, Florita M, Altomare G, et al. Increased plasma levels of platelet-derived growth factor activity inpatient swith progressive systemic sclerosis. Proc Soc Exp Biol Med, 1989, 191:1-4. 7 Gay S, Jones RE, Huang GQ, et al. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and cis-oncogene expression in scleroderma. J Inve t Dermatol, 1989, 92:301-304. |